- Home
- PLRX vs NMCO Comparison
PLRX vs NMCO Comparison
Compare PLRX & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- NMCO
- Stock Information
- Founded
- PLRX 2015
- NMCO 2019
- Country
- PLRX United States
- NMCO United States
- Employees
- PLRX N/A
- NMCO N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- NMCO Finance/Investors Services
- Sector
- PLRX Health Care
- NMCO Finance
- Exchange
- PLRX Nasdaq
- NMCO Nasdaq
- Market Cap
- PLRX 680.3M
- NMCO 603.4M
- IPO Year
- PLRX 2020
- NMCO N/A
- Fundamental
- Price
- PLRX $11.37
- NMCO $11.11
- Analyst Decision
- PLRX Strong Buy
- NMCO
- Analyst Count
- PLRX 7
- NMCO 0
- Target Price
- PLRX $40.50
- NMCO N/A
- AVG Volume (30 Days)
- PLRX 485.5K
- NMCO 207.6K
- Earning Date
- PLRX 02-26-2025
- NMCO 01-01-0001
- Dividend Yield
- PLRX N/A
- NMCO 5.43%
- EPS Growth
- PLRX N/A
- NMCO N/A
- EPS
- PLRX N/A
- NMCO N/A
- Revenue
- PLRX N/A
- NMCO N/A
- Revenue This Year
- PLRX N/A
- NMCO N/A
- Revenue Next Year
- PLRX N/A
- NMCO N/A
- P/E Ratio
- PLRX N/A
- NMCO N/A
- Revenue Growth
- PLRX N/A
- NMCO N/A
- 52 Week Low
- PLRX $10.22
- NMCO $8.52
- 52 Week High
- PLRX $18.00
- NMCO $11.64
- Technical
- Relative Strength Index (RSI)
- PLRX 44.60
- NMCO 70.31
- Support Level
- PLRX $10.35
- NMCO $10.69
- Resistance Level
- PLRX $11.07
- NMCO $10.98
- Average True Range (ATR)
- PLRX 0.61
- NMCO 0.12
- MACD
- PLRX 0.06
- NMCO 0.04
- Stochastic Oscillator
- PLRX 43.50
- NMCO 93.88
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About NMCO Nuveen Municipal Credit Opportunities Fund
Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.